| Literature DB >> 35055080 |
María Mondéjar-López1, Alberto José López-Jiménez1, Joaquín C García Martínez2,3, Oussama Ahrazem1, Lourdes Gómez-Gómez1, Enrique Niza1.
Abstract
The current status of controversy regarding the use of certain preservatives in cosmetic products makes it necessary to seek new ecological alternatives that are free of adverse effects on users. In our study, the natural terpene thymoquinone was encapsulated in chitosan nanoparticles. The nanoparticles were characterized by DLS and TEM, showing a particle size of 20 nm. The chemical structure, thermal properties, and release profile of thymoquinone were evaluated and showed a successful stabilization and sustained release of terpenes. The antimicrobial properties of the nanoparticles were evaluated against typical microbial contaminants found in cosmetic products, showing high antimicrobial properties. Furthermore, natural moisturizing cream inoculated with the aforementioned microorganisms was formulated with thymoquinone-chitosan nanoparticles to evaluate the preservative efficiency, indicating its promising use as a preservative in cosmetics.Entities:
Keywords: antimicrobial; chitosan; cosmetic; essential oils; nanoparticles; nanotechnology; preservative agents
Mesh:
Substances:
Year: 2022 PMID: 35055080 PMCID: PMC8778794 DOI: 10.3390/ijms23020898
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
DLS measures, encapsulation efficiency (EE%), and efficient loading (EL%) of nano-formulations.
| Formulation | Average Size (nm) | PDI | Z-Value (mV) | EE% | EL% |
|---|---|---|---|---|---|
| NPCH | 48.6 ± 3.40 | 0.4 ± 0.02 | +49.8 ± 0.75 | - | - |
| NPCH-TQ 1:0.25 | 65.0 ± 1.40 | 0.4 ± 0.01 | +35.8 ± 3.23 | 88.2 ± 6.39 | 44.8 ± 0.70 |
| NPCH-TQ 1:0.5 | 57.5 ± 0.36 | 0.3 ± 0.01 | +27.8 ± 1.13 | 93.2 ± 2.05 | 48.4 ± 1.14 |
| NPCH-TQ 1:0.75 | 57.5 ± 0.33 | 0.2 ± 0.01 | +25.3 ± 0.76 | 94.5 ± 1.94 | 48.8 ± 1.24 |
| NPCH-TQ 1:1 | 63.4 ± 0.65 | 0.2 ± 0.01 | +23.9 ± 0.58 | 90.6 ± 10.4 | 50.7 ± 8.70 |
Figure 1TEM micrograph of (A) NPCH and (B) NPCH-TQ 1:1.
Figure 2In vitro drug release of NPCH-TQ in PBS at pH 6.
Figure 3DPPH scavenging of free TQ, NPCH, and NPCH-TQ.
Minimum inhibitory concentrations (µg/mL) of control drugs (Gentamicin (*) and Tebuconazole (**)), TQ, NPCH, and NPCH-TQ.
| Microorganism | Control MIC (µg/mL) | TQ (µg/mL) | NPCH (µg/mL) | NPCH-TQ (µg/mL) |
|---|---|---|---|---|
|
| * 1000 | 1000 | 1000 | 292 |
|
| * 1000 | >1000 | 1000 | 417 |
|
| * 1000 | >1000 | >1000 | 333 |
|
| ** 250 | 333 | >1000 | 250 |
|
| ** 250 | 250 | >1000 | 500 |
Cream composition. A (Aqueous phase), B (Oil phase), and C (thermolabile compounds).
| Ingredient | Control Cream (%) | NPCH-TQ Cream (%) |
|---|---|---|
| Water (A) | 47 | 46.5 |
| Vegetable glycerin (A) | 10 | 10 |
| Urea (A) | 3 | 3 |
| Glyceryl monostearate (B) | 8 | 8 |
| Argania spinosa kernel oil (B) | 28 | 28 |
| Allantoin (C) | 0.4 | 0.4 |
| Avena sativa extract (C) | 3 | 3 |
| Vitamin E (C) | 0.5 | 0.5 |
| Parfum (C) | 0.1 | 0.1 |
| NPCH-TQ (C) | - | 0.5 |
Figure 4Preservative activity of control cream vs. NPCH-TQ.